Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan®) and methylprednisolone acetate on primary osteoarthritis of the knee

Osteoarthritis and Cartilage

Volumn 9, Issue 4, 2001, Pages 371-381

  Guidolin, D D ^a   Ronchetti, I Pasquali ^b   Lini, E ^a   Guerra, D ^b   Frizziero, L ^c  

^a Fidia Advanced Biopolymers   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

Cartilage; Hyaluronan; Morphometry; Osteoarthritis

Indexed keywords

ANALGESIC AGENT; HYALURONIC ACID; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALYSIS; ARTICLE; ARTICULAR CARTILAGE; BIOPSY; CARTILAGE CELL; CATABOLISM; CELL COUNT; CELL DENSITY; CELL FUNCTION; CELL METABOLISM; CELL ORGANELLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; MORPHOLOGY; MORPHOMETRICS; PARAMETER; PRIORITY JOURNAL; SAMPLE; SURFACE PROPERTY; SYNOVIAL FLUID; VISCOELASTICITY;

EID: 0342561547     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2000.0398     Document Type: Article

References (43)

1. Dieppe P. Osteoarthritis: risk factors, process and outcome. Rheumatology Europe. 24:1995;66-68.
2. Lequesne M, Brandt K, Bellamy N, Moskowitz R, Menkes CJ, Pelletier JP. Guidelines for testing slow-acting drugs in osteoarthritis. J Rheumatol. 21:1994;65-71.
3. Ann Rheum Dis. 55:1996;552-557.
4. Guerra D, Frizziero L, Losi M, Bacchelli B, Mezzadri G, Pasquali-Ronchetti I. Ultrastructural identification of a membrane-like structure on the surface of normal articular cartilage. J Submicrosc Cytol Pathol. 28:1996;385-393.
5. Swann DA, Redin TL, Navimien M, Weisser PA, Curran N, Lewinnek G. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis. 33:1974;318-326.
6. Balazs EA. Physical properties of synovial fluid. Helfet A. Disorders of the Knee. 1974;63-73 Lippincot Co, Philadelphia.
7. Dahl LB, Dahl IM, Enstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 44:1985;817-822.
8. Rydell NW, Butler J, Balazs EA. Hyaluronic acid in synovial fluid. VI. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet Scand. 11:1970;139-155.
9. Peyron JG, Balasz EA. Preliminary clinical assessment of NA-hyaluronate injection into human arthritic joint. Pathol Biol. 22:1974;731-736.
10. ®(sodium hyaluronate) in the treatment of osteoarthritis of human knee. Semin Arthritis Rheum. 11:1981;143-144.
11. Peyron JG. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthr Cartil. 1:1993;85-87.
12. Aviad AD, Houpt JB. The molecular weight of therapeutic hyaluronan (sodium hyaluronate) how significant is it? J Rheumatol. 21:1994;297-301.
13. Carabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm. 15:1995;25-31.
14. Scali JJ. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long term study. Eur J Rheumatol Inflamm. 15:1995;57-62.
15. Rydell NW, Balazs EA. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and granulation tissue formation. Clin Orthop. 80:1971;25-32.
16. Kolarz G, Kotz R, Broll H, Dunky A, Landsiedl F, Mayrhofer F. Hyaluronic acid in the treatment of osteoarthritis of the knee joint: interim results of a comparative clinical study. Eur J Rheumatol Inflamm. 15:1995;39-45.
17. ®) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol. 25:1998;2203-2212.
18. Abatangelo G, Botti P, Del Bue M, Gei G, Samson J, Cortivo R. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin Orthop Rel Res. 241:1989;278-285.
19. Schiavinato A, Lini E, Guidolin D, Pezzoli G, Botti P, Martelli M. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop Rel Res. 241:1989;286-299.
20. Ghosh P, Burkhardt D, Read R, Bellenger C. Recent advances in animal models for evaluating chondroprotective drugs. J Rheumatol. 18:1991;143-146.
21. Listrat V, Xavier A, Patarnello F. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartil. 5:1997;153-160.
22. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: Clinical and morphological study. Clin Exp Rheumatol. 16:1998;441-449.
23. Altman RD, Asche E, Bloch D. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum. 29:1986;1039-1049.
24. Ghadially FN. Fine Structure of the Synovial Joints. 1983;Butterworths, London.
25. Eggli PS, Hunziker EE, Schenk RK. Quantitation of structural features characterizing weight- and less weight-bearing regions in articular cartilage: a stereological analysis of medial femoral condyles in young adult rabbits. Anat Rec. 222:1988;217-227.
26. Hacker SA, Healey RM, Yoshioka M, Coutts RD. A methodology for the quantitative assessment of articular cartilage histomorphometry. Osteoarthritis Cart. 5:1997;343-355.
27. Annefeld M. A new test method for the standardized evaluation of changes in the ultrastructure of chondrocytes. Int J Tiss Reac. 7:1985;273-289.
28. Weibel ER. Stereological Methods. Vol. I. 1979;Academic Press, London.
29. Winer BJ. Statistical Principles in Experimental Design. 1971;McGraw-Hill, Tokyo.
30. Carrabba M, Colombo B, Govoni E, Cenacchi G. Ultrastructural approach to the understanding of osteoarthrosis. Rheumatology. 7:1982;53-63.
31. Hunziker EB. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable? Osteoarthritis Cartil. 7:1999;15-28.
32. Hunziker EB, Rosenberg LC. Induction of repair in partial-thicness articular cartilage lesions by timed release of TGF-β (Abstract). Trans Orthop Res Soc. 1994;236-241.
33. Van Valburg AA, van Roermund PM, Marijnissen ACA, van Melkebeek J, Lammens J, Verbout AJ. Joint distraction in treatment of osteoarthritis: a two-year follow-up of the ankle. Osteoarthritis Cartil. 7:1999;474-479.
34. Van Valburg AA, van Roermund PM, Marijnissen ACA, Wenting JG, Verbout AJ, Lafeber FPJG. Joint distraction in treatment of osteoarthritis (II): effects on cartilage in a canine model. Osteoarthritis Cart. 8:2000;1-8.
35. Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 11:1999;417-421.
36. Ravaud P, Moulinier L, Giraudeau B, Ayral X, Guerin C, Noel E. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum. 42:1999;475-482.
37. Pelletier JP, Martel-Pelletier J, Malemud CJ, Woessner JF Jr. Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage and the effect of intraarticular steroid injections. Arthritis Rheum. 30:1987;541-548.
38. Pelletier JP, Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum. 32:1989;181-193.
39. Pelletier JP, DiBattista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. Lab Invest. 72:1995;578-586.
40. Williams JM, Brandt KD. Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum. 28:1985;1267-1274.
41. Caron JP, Tardif G, Martel-Pelletier J, DiBattista JA, Geng C, Pelletier JP. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res. 57:1996;1631-1634.
42. Creamer P, Sharif M, George E, Meadows K, Cushnaghan J, Shinmei M. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthr Cart. 2:1994;133-140.
43. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int. 7:1987;113-122.